ArticleMedicina (Kaunas, Lithuania)2025
Incidence of and Risk Factors for Anti-PD-1/PD-L1- Associated Diarrhea and Colitis: A Retrospective Cohort Study of the Chinese Population.
Wei Chen, Yan Wang, Mengyu Zhao, Hong Zhang, Ye Zong, Xinyan Zhao
Abstract read
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Wei ChenBeijing Digestive Disease Center, National Clinical Research Center for Digestive Disease, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Yan WangLiver Research Center, National Clinical Research Center for Digestive Disease, Key Laboratory on Translational Medicine on Cirrhosis, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Mengyu ZhaoLiver Research Center, National Clinical Research Center for Digestive Disease, Key Laboratory on Translational Medicine on Cirrhosis, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Hong ZhangDepartment of Pharmacy, Wenzhou Integrated Traditional Chinese and Western Medicine Hospital, Wenzhou 325000, China.
Ye ZongBeijing Digestive Disease Center, National Clinical Research Center for Digestive Disease, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID 0009-0000-2448-6365 Xinyan ZhaoLiver Research Center, National Clinical Research Center for Digestive Disease, Key Laboratory on Translational Medicine on Cirrhosis, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID 0000-0002-8016-4368 Funding
Beijing Friendship Hospital YYZZ202215National Key R&D Program of China 2021ZD0113200
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
ColitisDiarrheaImmune Checkpoint InhibitorsAdultAgedAged, 80 and overChinaCohort StudiesEast Asian PeopleFemaleHumansIncidenceMaleMiddle AgedRetrospective StudiesRisk FactorsImmune Checkpoint InhibitorsChineseimmune checkpoint-associated diarrhea and colitis (IMDC)incidencerisk factors
Identifiers
PMID40005469
PMCPMC11857649
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390